secwatch / observer
8-K filed April 18, 2023, 7:59 PM ET ticker DFTX CIK 0001813814
leadership confidence high sentiment neutral materiality 0.15

Director Brigid A. Makes to leave MindMed board at 2023 annual meeting

Definium Therapeutics, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brigid A. Makes

Director
DFTX · Definium Therapeutics, Inc.
Filed
April 18, 2023, 7:59 PM ET
On April 15, 2023, after extensive consideration and discussion with the Board of Directors (the “ Board ”) of Mind Medicine (MindMed) Inc. (the “ Company ”), Brigid A. Makes provided notice to the Board of her decision not to stand for re-election at the Company’s 2023 annual general meeting of shareholders (the “ Annual Meeting ”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brigid A. Makes departed as Director at Definium Therapeutics, Inc..

Action
not to stand for re-election
Role
Director
Exact text from the filing
On April 15, 2023, after extensive consideration and discussion with the Board of Directors (the “ Board ”) of Mind Medicine (MindMed) Inc. (the “ Company ”), Brigid A. Makes provided notice to the Board of her decision not to stand for re-election at the Company’s 2023 annual general meeting of shareholders (the “ Annual Meeting ”).
View on SEC.gov

Definium Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-104977
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.